Word mark

Trademark: 'INFINITY PHARMACEUTICALS' 
Infinity Pharmaceuticals, Inc.
European Community Trademark, no. 002547214, Word mark

 

On 11. 1. 2002 the community trademark application no. 002547214 was filed for INFINITY PHARMACEUTICALS (Word mark) by Infinity Pharmaceuticals, Inc. before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 1, 5, 9 and 42. The current status of the trademark is registered.

Status is 'Registered'
The Community Trade Mark has been registered for the European Union.

Registered28. 1. 2004
Expiry date11. 1. 2022
Nice classes1, 5, 9, 42

 
 

You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.

 

Owner

Infinity Pharmaceuticals, Inc.
780 Memorial Drive
02139 Cambridge,
US

 

If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89

Representative

WITHERS & ROGERS LLP
4 More London Riverside
SE1 2AU London
GB

 

If the data above is not correct, then please choose Update.

 
 

Nice classes

1  Diagnostic assays and test kits for clinical, laboratory and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteonic profiles useful in the selection of therapeutics; assays and test kits for evaluating efficacy of treatments and treatment progress; prognostic test kits for identifying hereditary risk factors; diagnostic preparations, namely, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies and molecular arrays of biological materials for clinical or medical laboratory use; diagnostic assays and test kits for scientific, research and medical research use to diagnose, prognose, predict or treat diseases and for providing genomic and proteonic profiles useful in the selection of therapeutics.

5  Prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral urinary, renal, infectious, metabolic or central nervous system diseases and disorders, excluding analgesics; diagnostic assays and test kits for clinical, laboratory, medical and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteomic profiles useful in the selection of therapeutics; assays and test kits for evaluating efficacy of treatments and treatment progress; prognostic test kits for identifying hereditary risk factors; diagnostic preparations, namely, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory use.

9  Computer programs and databases stored on CD-ROM in the field of genomics, diagnostics, pharmacogenomics, pharmaceuticals and biotechnology; computer programs for use in database management, integration and manipulation; computer programs for use in characterization of nucleic acid and protein information; computer programs for use in analyzing chemical structure and activity information; computer programs for use in acquisition and interrogation of clinical, pathological, diagnostic, genetic, genomic and biochemical data; computer programs for use in clinical trial design and management; computer programs for use in text and pattern recognition; computer programs for storage, retrieval and analysis of life sciences literature; computer programs for use in managing robot function; computer programs for use in processing toxicological and pharmacological information; computer programs for laboratory instrument control; computer programs for use in control of sample input to mass spectrometers; computer programs for use in spectral analysis; pre-recorded CD-ROMs featuring databases containing life sciences information; pre-configured microprocessors for analysis and storage of life sciences information.

42  Medical and diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, namely, providing access to databases of life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology.

 
 
 

Records history

 
11.1.2022 Expiry
Expiry date of the trademark 002547214 INFINITY PHARMACEUTICALS
5.12.2016 The current state is Registered
Current state
19.12.2011 Trade mark renewed
D.1 Renewal of a mark
13.9.2011 Published
Representative - Change of name and professional address
2.11.2009 Published
Proprietor - Change of name and address
11.12.2007 Published
Representative - Change of name and professional address
13.8.2007 Published
Representative - Change of name and professional address
28.1.2004 Registration
Registration of the trademark 002547214 INFINITY PHARMACEUTICALS
11.1.2002 Application
Application of the trademark 002547214 INFINITY PHARMACEUTICALS
 

Further trademarks of the owner